KALA BIO(KALA.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
KALA BIO
KALA.US
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company’s lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases.
1.955 T
KALA.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Nexalin Technology Receives Nasdaq Listing Status Notification | NXL Stock News

    Nexalin Technology, Inc. (Nasdaq: NXL) has received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company has 180 days, until July 20, 2026, to regain compliance by maintaining the required bid price for 10 consecutive trading days. The notification does not affect the current trading of NXL shares. Nexalin is exploring measures to improve its financial position but is not considering a reverse stock split at this time.

    StockTitan·
    US
    SBIO
    -3.01%
    US
    BBH
    -0.45%
    US
    NXL
    -3.90%
    StockTitan·
    US
    SBIO
    -3.01%
    US
    BBH
    -0.45%
    US
    NXL
    -3.90%

    U.S. stock market movement update: ZeZentalis Pharma leads with a 33% increase, flyExclusive drops nearly 14%

    Overview of the US Stock Market In the past hour, the US stock market has shown a clear characteristic of sector rotation, with the pharmaceutical and real estate sectors performing particularly well. The flow of funds indicates a preference for small-cap stocks and thematic stocks, especially the strong performance of pharmaceutical stocks is noteworthy. Market sentiment is active, with significant volatility, and short-term enthusiasm continues to rise. The stock with the largest movement in the past hour, ZeZentalis Pharma, leads the market with a 33.10% increase, supported by the strong performance of the pharmaceutical sector. The concentrated inflow of funds has driven its stock price up, with short-term sentiment running high. Strong stocks: 1. Wheeler Real Estate: up 24.04%, driven by the active performance of the real estate sector. 2. 3D: up 14.06%, benefiting from the recovery of technology stocks. 3. Revolution Medicines: up 13.07%, boosted by the overall strength of the pharmaceutical sector. 4. Icon Energy: up 11.80%, with inflows into the energy sector pushing its stock price higher. 5. Opendoor Tech: up 11.51%, benefiting from market preference for technology stocks. 6. Fathom: up 10.00%, driven higher by active participation of short-term funds. 7. HUYA: up 8.71%, supported by the active performance of the entertainment sector

    Tracking Unusual Activity·
    US
    KALA
    +2.54%
    Tracking Unusual Activity·
    US
    KALA
    +2.54%

    U.S. stock movement update: Wheeler up over 26%, flyExclusive down 17%, tech stocks active

    Overview of the US Stock Market In the past hour, the US stock market has shown a clear sector rotation phenomenon. Stocks in the real estate and technology sectors have performed particularly well, with significant capital inflows driving the rise of related stocks. Meanwhile, the pharmaceutical sector has experienced divergence, with some stocks under pressure. The overall market pace is fast, with high short-term enthusiasm and active investor sentiment. The stock with the largest movement, Wheeler Real Estate, leads the market with a 26.23% increase. Driven by strong capital, the stock has shown a robust upward momentum, supported by the overall activity in the real estate sector. Strong stocks: 1. 3D: up 12.50%, with capital inflows in the technology sector boosting its price, and the market is full of expectations for its future development. 2. Revolution Medicines: up 12.36%, with some funds in the pharmaceutical sector shifting to this stock, driving its rise. 3. Opendoor Tech: up 11.04%, with the activity in the real estate market driving the stock's increase. 4. Icon Energy: up 10.87%, with capital inflows in the energy sector making it perform strongly. 5. Fathom: up 10.77%, with the market's optimism about its future growth potential pushing the stock price up. 6. Davis Commodities: up 10.33%, with fluctuations in the commodity market providing upward momentum

    Tracking Unusual Activity·
    US
    KALA
    +2.54%
    Tracking Unusual Activity·
    US
    KALA
    +2.54%

    U.S. stock market movement update: Real estate stocks lead the rise, Wheeler Real Estate up over 31%, biotechnology stocks generally decline

    Overview of the US Stock Market In the past hour, the US stock market has shown significant sector rotation characteristics, with the real estate and technology sectors performing particularly well. Wheeler Real Estate led the gains, driving the overall rise of the real estate sector, while in the tech stocks, the strong performance of Fathom and Icon Energy also attracted market attention. Fund flows indicate that investors prefer small-cap stocks and thematic stocks, with short-term enthusiasm clearly increasing and market sentiment active. The stock with the largest movement in the past hour, Wheeler Real Estate, became the market focus with a 31.15% increase. Its strong upward momentum not only reflects the overall activity of the real estate sector but also shows investors' optimistic expectations for the stock's future growth potential. The rapid inflow of funds has increased the stock's volatility, significantly enhancing the participation of short-term traders. Strong stocks: 1. Fathom: Up 19.23%, standing out in the technology sector, with active short-term fund involvement driving rapid price increases. 2. Icon Energy: Up 18.01%, benefiting from the overall recovery of the energy sector, with the market holding an optimistic view of its future development. 3. Revolution Medicines: Up 13.07%, supported by the continued strength of the pharmaceutical sector. 4. Opendoor Tech: Up 12.60%, with the active real estate market driving the stock's strong performance

    Tracking Unusual Activity·
    US
    KALA
    +2.54%
    US
    MASK
    -6.74%
    Tracking Unusual Activity·
    US
    KALA
    +2.54%
    US
    MASK
    -6.74%

    KALA BIO eliminates debt overhang through equity settlements

    KALA BIO has resolved a significant debt overhang by issuing 4.6 million common shares in equity settlements, including 900,000 shares to Baker Bros. Advisors and 2.2 million shares to LifeSci Capital. This move extinguished approximately $10.6 million of debt owed to Oxford Finance, enhancing the company's financial flexibility. Despite this, analysts rate KALA stock as a Hold with a $0.59 price target, citing weak financial performance and ongoing risks. KALA BIO focuses on developing therapies for eye diseases and is listed on Nasdaq.

    Tip Ranks·
    US
    KALA
    +2.54%
    Tip Ranks·
    US
    KALA
    +2.54%
    © 2026 Longbridge｜Disclaimer